Diagnostics Pipeline: To Gain Insight into Haystack MRD Test, Quest Works with City of Hope
New liquid biopsy assay will be used in conjunction with 500 cancer patients currently enrolled in clinical trials
Already a member? Log in here
Clinical Diagnostics Insider
(formerly Diagnostic Testing and Emerging Technologies)
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
Quest Diagnostics Launches Consumer-Facing AI on Its App and Portal
The company’s patients can use AI to look at trends going back five years
Already a member? Log in here
Thermo Fisher Scientific Debuts Pharmacogenetic Test to Improve Transplant Safety
Proper dosing helps prevent potential side effects such as developing diabetes and kidney damage
Already a member? Log in here
Protein Markers May Eliminate Need for Biopsies in Infertile Men
...
Already a member? Log in here
PGx Adoption Still Slow; Outcomes Benefits Inconclusive
...
Already a member? Log in here
National Sequencing Efforts Aim to Boost Use of Genomic Information
...
Already a member? Log in here
G2 Insider: New Method Improves Accuracy of LDL-C Estimation
...
Already a member? Log in here
Routine CBC Could Provide Added Mortality Risk Information
...
Already a member? Log in here
Broad Guidance Needed to Aid Biobank Sample Stewardship
...
Already a member? Log in here